Atorvastatin Calcium
Product Images NDC 70934-091
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-01 (Figure 01)
Figure-02 (Figure 02)
This appears to be a medical chart or graph showing the cumulative hazard percentage over a period of up to 4 years of follow-up. Atorvastatin, a medication used to lower cholesterol, is mentioned with its corresponding hazard ratio. The chart has values of 15 and 10 on its vertical axis, as well as a horizontal axis labeled "time to first primary endpoint."*
Figure-03 (Figure 03)
This text represents a table displaying the percentage of subjects experiencing E vert (presumably a side effect) for two different medications, Horvastatin 10 mg and Sorvastatin 80 mg. Additionally, there is information regarding the efficacy of each medication in reducing major cardiovascular end points over time. The text indicates that Horvastatin appears to have a statistically significant reduction in these end points compared to Sorvastatin.*
Chemical-structure (Chemical Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.